Correlation Between Eliem Therapeutics and Werewolf Therapeutics
Can any of the company-specific risk be diversified away by investing in both Eliem Therapeutics and Werewolf Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eliem Therapeutics and Werewolf Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eliem Therapeutics and Werewolf Therapeutics, you can compare the effects of market volatilities on Eliem Therapeutics and Werewolf Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eliem Therapeutics with a short position of Werewolf Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eliem Therapeutics and Werewolf Therapeutics.
Diversification Opportunities for Eliem Therapeutics and Werewolf Therapeutics
0.02 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Eliem and Werewolf is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Eliem Therapeutics and Werewolf Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Werewolf Therapeutics and Eliem Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eliem Therapeutics are associated (or correlated) with Werewolf Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Werewolf Therapeutics has no effect on the direction of Eliem Therapeutics i.e., Eliem Therapeutics and Werewolf Therapeutics go up and down completely randomly.
Pair Corralation between Eliem Therapeutics and Werewolf Therapeutics
Given the investment horizon of 90 days Eliem Therapeutics is expected to generate 0.97 times more return on investment than Werewolf Therapeutics. However, Eliem Therapeutics is 1.03 times less risky than Werewolf Therapeutics. It trades about -0.22 of its potential returns per unit of risk. Werewolf Therapeutics is currently generating about -0.26 per unit of risk. If you would invest 392.00 in Eliem Therapeutics on August 31, 2024 and sell it today you would lose (88.00) from holding Eliem Therapeutics or give up 22.45% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 95.45% |
| Values | Daily Returns |
Eliem Therapeutics vs. Werewolf Therapeutics
Performance |
| Timeline |
| Eliem Therapeutics |
| Werewolf Therapeutics |
Eliem Therapeutics and Werewolf Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eliem Therapeutics and Werewolf Therapeutics
The main advantage of trading using opposite Eliem Therapeutics and Werewolf Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eliem Therapeutics position performs unexpectedly, Werewolf Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Werewolf Therapeutics will offset losses from the drop in Werewolf Therapeutics' long position.| Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
| Werewolf Therapeutics vs. Monte Rosa Therapeutics | Werewolf Therapeutics vs. Design Therapeutics | Werewolf Therapeutics vs. Ikena Oncology | Werewolf Therapeutics vs. Stoke Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |